Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Milestone Pharmaceuticals Inc. | CFO & EVP of Corp. Development | Common Shares | 50K | $60K | $1.20 | Jul 11, 2025 | Direct |
Milestone Pharmaceuticals Inc. | CFO & EVP of Corp. Development | Employee Stock Option (right to buy) | 121K | Jan 27, 2025 | Direct | ||
Milestone Pharmaceuticals Inc. | CFO & EVP of Corp. Development | Restricted Stock Unit | 80.4K | Jan 27, 2025 | Direct | ||
Milestone Pharmaceuticals Inc. | CFO & EVP of Corp. Development | Series A Common Warrants (right to buy) | 50K | Jul 11, 2025 | Direct | ||
Milestone Pharmaceuticals Inc. | CFO & EVP of Corp. Development | Series B Common Warrants (right to buy) | 50K | Jul 11, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MIST | Milestone Pharmaceuticals Inc. | Jul 11, 2025 | 3 | $0 | 4 | Jul 15, 2025 | CFO & EVP of Corp. Development |
MIST | Milestone Pharmaceuticals Inc. | Jan 27, 2025 | 2 | $0 | 4 | Jan 29, 2025 | CFO & EVP of Corp. Development |
MIST | Milestone Pharmaceuticals Inc. | Feb 16, 2023 | 1 | $0 | 4 | Feb 17, 2023 | CFO & EVP of Corp. Development |
MIST | Milestone Pharmaceuticals Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 23, 2022 | CFO & EVP of Corp. Development |